MONTREAL, May 24, 2011 /PRNewswire/ - Aptilon Corporation
("Aptilon" or the "Company") (TSX-V: APZ), a leader in online
access to, engagement and interaction with physicians and
healthcare professionals on behalf of pharmaceutical and life
sciences companies, today announced that its indirect wholly-owned
subsidiaries, DMD Marketing LP and DMD Marketing Corp., have come
to an agreement to extend the repayment period of the secured
promissory note in the amount of US$27,200,000 issued in September 2009 in connection with the purchase of
substantially all the assets of Direct Medical Data, LLC. and BLM
Incorporated related to their healthcare marketing services. The
original note provided for monthly installments, and a lump sum
payment of approximately US$12,417,000 on September 15, 2012.
The original note is replaced by a new secured promissory note
in the amount of US$21,750,000, being
the balance due under the original note as of April 14, 2011. The new note bears interest
at the rate of 6.9% per annum and is repayable in increasing
monthly installments (ranging from US$226,000 for the first 9 months to US$600,000 for 11 of the last 12 months) from
April 15, 2011 until
December 15, 2015. It is secured
and guaranteed in the same manner as the original note.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device
companies to effectively reach, message, connect and interact with
US physicians and healthcare professionals on the Internet and over
mobile devices via multiple access channels. Its innovative service
offerings provide targeted impressions and interactions through:
video and mobile detailing, ReachNet℠ Physician Access
Channel, the DMD database and permission-based email services. Top
US pharmaceutical companies and respected healthcare organizations
have adopted Aptilon's solutions to market to, engage and interact
with leading healthcare practitioners. For more information, visit
www.aptilon.com.
ReachNetSM is a service mark of Aptilon
Corporation.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Aptilon Corporation
